Qube Research & Technologies (QRT)
BNR

Qube Research & Technologies (QRT)’s Burning Rock Biotech BNR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-780
Closed -$230K – 2227
2021
Q2 		$230K Sell
780
-228
-23% -$67.5K ﹤0.01% 1725
2021
Q1 		$271K Sell
1,008
-734
-42% -$223K ﹤0.01% 1509
2020
Q4 		$402K Buy
+1,742
New +$468K 0.01% 1226

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BNR Position: Q3 2021 in Review

Qube Research & Technologies (QRT) sold out of Burning Rock Biotech (BNR) in Q3 2021, closing a stake of 780 shares — an estimated $230K sold.

Qube Research & Technologies (QRT) first reported a position in BNR in Q4 2020 and held it in 3 quarters. The position peaked at $402K in Q4 2020. 86 funds tracked by Wall St. Rank hold BNR as of Q3 2021.

  • Qube Research & Technologies (QRT) reported no remaining Burning Rock Biotech position as of Q3 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 780 Burning Rock Biotech shares in Q3 2021, an estimated $230K.
  • Qube Research & Technologies (QRT) first reported a position in Burning Rock Biotech in Q4 2020 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Burning Rock Biotech position peaked at $402K in Q4 2020.
  • 86 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2021, filed 12 Nov 2021.